Harnessing mixed chimerism and programmed cell death protein 1/programmed death ligand 1 signaling for transplant tolerance

被引：0
|
作者：
Li, Shuang [2 ]
Zou, Dawei [1 ,3 ]
机构：
[1] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA
[2] Houston Methodist Hosp, Houston Methodist Res Inst, Immunobiol & Transplant Sci Ctr, Dept Surg, Houston, TX USA
[3] Houston Methodist Hosp, Houston Methodist Res Inst, Immunobiol Transplant Sci Ctr, 6670 Bertner Ave,R7-430-3, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2024年 / 24卷 / 01期
关键词：
T cell; transplant tolerance; mixed chimerism; PD-1/PD-L1; T cell exhaustion; T cell anergy;
D O I：
10.1016/j.ajt.2023.09.016
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [1] Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors
    Pezeshki, Parmida Sadat
    Mahdavi Sharif, Pouya
    Rezaei, Nima
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (12) : 1575 - 1590
  • [2] Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
    Debasree Banerjee
    Sean Monaghan
    Runping Zhao
    Thomas Walsh
    Amy Palmisciano
    Gary S. Phillips
    Steven Opal
    Mitchell M. Levy
    Critical Care, 22
  • [3] Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis
    Banerjee, Debasree
    Monaghan, Sean
    Zhao, Runping
    Walsh, Thomas
    Palmisciano, Amy
    Phillips, Gary S.
    Opal, Steven
    Levy, Mitchell M.
    CRITICAL CARE, 2018, 22
  • [4] Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway
    Wang, Tianyu
    Wu, Xiaoxing
    Guo, Changying
    Zhang, Kuojun
    Xu, Jinyi
    Li, Zheng
    Jiang, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (04) : 1715 - 1730
  • [5] Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for chimerism
    Huang, Yaxun
    Wu, Xiwei
    Tang, Shanshan
    Wu, Huiqing
    Nasri, Ubaydah
    Qin, Qi
    Song, Qingxiao
    Wang, Bixin
    Tao, Hansen
    Chong, Anita S.
    Riggs, Arthur D.
    Zeng, Defu
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (08) : 1116 - 1129
  • [6] Expression of programmed cell death ligand 1 and programmed cell death 1 in cutaneous warts
    Yu, Wesley Y.
    Berger, Timothy G.
    North, Jeffrey P.
    Laszik, Zoltan
    Cohen, Jarish N.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (05) : 1127 - 1133
  • [7] Prognostic implication of programmed cell death 1 protein and programmed cell death 1 ligand 1 expression in endometrial cancer
    Kim, J.
    Choi, J. H.
    Kong, J.
    Yang, W.
    Cho, H.
    Chay, D. B.
    Kim, J. H.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 47 - 47
  • [8] Expression of programmed cell death protein 1 and programmed cell death ligand 1 in feline injection site fibrosarcomas
    Mikiewicz, Mateusz
    Pazdzior-Czapula, Katarzyna
    Fiedorowicz, Joanna
    Otrocka-Domaga, Iwona
    RESEARCH IN VETERINARY SCIENCE, 2024, 176
  • [9] There Is an Unmet Need for Another Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Inhibitor
    Feng, Jamie
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (10) : 1175 - 1177
  • [10] PROGRAMMED CELL DEATH PROTEIN 1 AND PROGRAMMED DEATH LIGAND 1 EXPRESSION IN NEUROENDOCRINE CARCINOMAS OF THE URINARY BLADDER
    Acikalin, Arbil
    Bagir, Emine
    Inceman, Merve
    Deger, Mutlu
    Erdogan, Seyda
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (04) : 307 - 313
12345